High Throughput Prediction of Oral Absorption: Improvement of the Composition of the Lipid Solution Used in Parallel Artificial Membrane Permeation Assay
Free accessResearch articleFirst published online June, 2001
High Throughput Prediction of Oral Absorption: Improvement of the Composition of the Lipid Solution Used in Parallel Artificial Membrane Permeation Assay
The purpose of the present study was to improve the composition of the lipid solution used in parallel artificial membrane permeation assay for the precise prediction of oral absorption. We modified the composition of lipid solution, which was used to make a lipid membrane on the filter support. First, we changed the chain length of organic solvent (PC/alkyldienes [C7-C10]). A negative charge was then added to the membrane to mimic the intestinal membrane (PC/stearic acid/1,7-octadiene and PC/PE/PS/PI/cholesterol/1,7-octadiene). Finally, we examined the predictability of the PC/PE/PS/PI/CHO/1,7-octadiene membrane using structurally diverse compounds. Permeability coefficients of tested compounds were increased as the chain length of alkyldiene became shorter. The addition of a negative charge to the membrane increased the permeability of the basic compounds. However, the negatively charged membrane with stearic acid showed different permeability profiles from PC/PE/PSIPI/CHO. The predictability of the PC/PE/PS/PI/CHO/1,7-octadiene membrane was adequate (r = 0.858, n = 31) for use during the early stages of the drug discovery/development process.
References
1.
Venkatesh S, Lipper RA: Role of the development scientist in compound lead selection and optimization. J Pharm Sci2000;89:145-154.
2.
Artursson P, Karlsson J: Correlation between oral absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco2) cells. Biochem Biophys Res Commun1991;175:880-885.
3.
Yee S: In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man—fact or myth?Pharm Res1997;14:763-766.
4.
Chong S, Dondo SA, Soucek KM, et al: In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transport system. Pharm Res1996;13:120-123.
5.
Schaper KJ: Absorption of ionizable drugs: nonlinear dependence on logP, pKa and pH-quantitative relation ships. Quant Struct Act Relat1982;1:13-27.
6.
Yazdanian M, Glynn SL, Wright JL, et al: Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharm Res1998;15:1490-1494.
7.
Pidgeon C, Ong S, Liu H, et al: IAM chromatography: an in vitro screen for predicting drug membrane permeability. J Med Chem1995;38:590-594.
8.
Balon K, Reibesehl BU, Muller BW: Drug liposome partitioning as a tool for the prediction of human passive intestinal absorption. Pharm Res1999;16:882-888.
9.
Kansy M, Senner F, Gubernator K: Physicochemical high through-put screening: pallarel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem1998;41:1007-1010.
10.
Thompson M, Krull UJ, Worsfold PJ: The structure and electrochemical properties of a polymer-supported lipid biosenser. Anal Chim Acta1980;117:133-145.
11.
Maxwell JD, Watson WC, Watt JK, et al: Radiotelemetering studies of jejunal pH before and after vagotomy and pyloroplasty. Gut1968;9:612-616.
12.
Hogben CAM, Tacco DJ, Brodie BB, et al: On the mechanism of intestinal absorption of drugs. J Pharmacol Exp Ther1959;269:275-282.
13.
Diamond JM, Kats Y: Interpretation of nonelectrolyte partition coefficients between dimyristoyl lecithin and water. J Membr Biol1974;17:121-154.
14.
Xiang TX, Chen X, Anderson BD: Transport methods for probing the barrier domain of lipid bilayer membranes. Biophys J1992;63:78-88.
15.
Xiang TX, Anderson BD: Substituent contributions of the transport of substituted p-toluic acids across lipid bilayer membranes. J Pharm Sci1994;83:1511-1518.
16.
Winiwarter S, Bonham NM, Ax F, et al: Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters: a multivariate data analysis approach. J Med Chem1998;41:4939-4949.
17.
Wessel MD, Jurs PC, Tolan JW, et al: Prediction of human intestinal absorption of drug compounds from molecular structure. J Chen Inf Comput Sci1998;38:726-735.
18.
McEvoy GK (ed): AHFS Drug Information. CITY: American Society of Health-System Pharmacists, Bethesda, MD, 1998.
19.
Chiou WL, Barve A: Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res1998;15:1792-1795.
20.
Inui K, Tabara K, Hori R, et al: Black lipid membranes as a model for intestinal absorption of drugs. J Pharm Pharmacol1976;29:22-26.
21.
Kramer SD, Braun A, Jakits-Deiser C, et al: In Abstracts of the Annual Meeting of the AAPS, (abst S-665), American Association of Pharmaceutical Science, Arlington, VA, 1997:4093.
22.
Gennin RB: Biomembranes. Tokyo: Springer-Verlag Tokyo, 1989.
Paterson DA, Conradi RA, Hilgers AR, et al: A non-aquenous partitioning system for predicting the oral absorption potential of peptides. Quant Struct Act Relat1994;13:4-10.
25.
van de Waterbeemd H: The fundamental variables of the biopharmaceutics classification system (BCS): a commentary. Eur J Pharm Sci1998;7:1-3.
26.
Amidon GL, Lennernäs H, Shah VP, et al: A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res1995;12:413-420.
27.
Lennernäs H: Does fluid flow across intestinal mucosa affect quantitative oral drug absorption? Is it time for reevaluation?Pharm Res1995;12:1573-1582.
28.
Amidon GL, Sinko PJ, Fleisher D: Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res1988;5:651-654.
29.
Dunnington D: Contract screening: the case against. J Biomol Screen2000;5:119-122.
